These data suggest that in the liver of insulin-resistant rats with early stages of NAFLD, AT1 blockade increases nuclear Nrf2, potentially promoting antioxidant defenses. The gene discussed is NFE2L2; the disease is metabolic dysfunction-associated steatotic liver disease.